等待开盘 04-01 09:30:00 美东时间
0.000
0.00%
Ovid Therapeutics Inc. has appointed Dr. Petra Kaufmann as Chief Medical Officer. Dr. Kaufmann will oversee clinical, medical, and regulatory strategy as Ovid advances its pipeline of therapies for br...
2025-12-02 20:00
Liz Ann Sonders, the Chief Investment Strategist at Charles Schwab & Co. (NYSE: SCHW) highlighted certain unusual divergences in the small cap markets.
2025-10-10 16:27
Vigil Neuroscience (NASDAQ:VIGL) reported quarterly losses of $(0.56) per share which missed the analyst consensus estimate of $(0.42) by 32.08 percent. This is a 7.69 percent decrease over losses of $(0.52) per share
2025-08-05 21:37
An update from Vigil Neuroscience Inc ( ($VIGL) ) is now available. On August 4...
2025-08-05 21:28
Vigil Neuroscience, Inc. has announced that it has entered into an Agreement and Plan of Merger with Parent and Vesper Acquisition Sub Inc. Under the terms of the agreement, Vesper Acquisition Sub Inc...
2025-08-05 21:08
Vigil Neuroscience Inc ( ($VIGL) ) has issued an update. On May 21, 2025, Vigil...
2025-07-28 19:57
Vigil Neuroscience Inc ( ($VIGL) ) has shared an announcement. On May 21, 2025,...
2025-07-17 19:27
Vigil Neuroscience, Inc. has announced an update regarding its merger with Sanofi. The merger involves Vesper Acquisition Sub Inc., a wholly-owned subsidiary of Sanofi, merging into Vigil Neuroscience...
2025-07-17 19:06
NEW YORK, July 3, 2025 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders...
2025-07-04 05:34
New activity is brewing for Vigil Neuroscience Inc ( ($VIGL) ). The company has...
2025-06-30 23:56